Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.31M in the quarter ending June 30, 2025, with 1.91% growth. This brings the company's revenue in the last twelve months to $64.81M, down -9.94% year-over-year. In the fiscal year ending September 30, 2024, Enanta Pharmaceuticals had annual revenue of $67.64M, down -14.61%.

• Revenue (ttm): $64.81M
• Revenue Growth: -9.94%
• P/S Ratio: 2.48
• Revenue / Employee: $494,702
• Employees: 131
• Market Cap: 161.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	67.64M	-11.57M	-14.61%
Sep 30, 2023	79.20M	-6.96M	-8.07%
Sep 30, 2022	86.16M	-10.91M	-11.24%
Sep 30, 2021	97.07M	-25.40M	-20.74%
Sep 30, 2020	122.47M	-82.72M	-40.31%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.